Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Visceral leishmaniasis infection in a fingolimod-treated multiple sclerosis patient.
The clinico-radiological paradox in multiple sclerosis: novel implications of lesion size.
Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes.
Genetic inactivation of mitochondria-targeted redox enzyme p66ShcA preserves neuronal viability and mitochondrial integrity in response to oxidative challenges.
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.
Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients.
The co-occurrence of pain and depression in adults with multiple sclerosis.
Transverse myelitis following combined spinal-epidural anesthesia.
Pediatric Urinary Retention in the Emergency Department: A Concerning Symptom with Etiology Outside the Bladder.
Reproduction and the risk of multiple sclerosis.
An update on new and emerging therapies for relapsing-remitting multiple sclerosis.
Relationships among physical inactivity, deconditioning, and walking impairment in persons with multiple sclerosis.
Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Neuroinflammation: The role and consequences.
LIVER X RECEPTORS, NERVOUS SYSTEM AND LIPID METABOLISM.
Acute Transverse Myelitis Associated With Human Parvovirus B19 Infection.
Evoked potentials in multiple sclerosis.
[Understanding needs of people with Multiple Sclerosis. Perspective of patients and significant others in the German-speaking part of Switzerland].
Value of the MoCA Test as a Screening Instrument in Multiple Sclerosis.
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.
2010 McDonald criteria for diagnosing pediatric multiple sclerosis.
Clinically isolated syndromes suggestive of multiple sclerosis: an optical coherence tomography study.
Promotion and prevention of autoimmune disease by CD8+ T cells.
Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies.

Pages